Sacubitril/valsartan in chronic symptomatic heart failure: a real world experience of delivery and outcomes.

被引：0
|
作者：
Kearney, A. Aileen [1 ]
Hill, L. [1 ]
Davidson, J. [1 ]
Mc Clure, C. [1 ]
Dixon, L. [1 ]
机构：
[1] Royal Victoria Hosp, Belfast, Antrim, North Ireland
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1662
引用
收藏
页码：411 / 411
页数：1
相关论文
共 50 条
  • [31] “Real World” Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure Registry
    Joanne Simpson
    L. Benson
    P. S. Jhund
    U. Dahlström
    J. J. V. McMurray
    L. H. Lund
    Cardiovascular Drugs and Therapy, 2019, 33 : 315 - 322
  • [32] The PARASAIL study Patient reported outcomes from the Canadian real world experience use of sacubitril/valsartan in patients with heart failure and reduced ejection fraction
    Haddad, H.
    Bergeron, S.
    Ignaszewski, A.
    Searles, G.
    Bastien, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 34 - 34
  • [33] Influence of sacubitril-valsartan on outcomes of patients with chronic heart failure in different populations: Brazil and Portugal experience.
    Ferreira, F. C.
    Ricardo Mourilhe Rocha, R.
    Spineti, P. P. M.
    Bittencourt, M. I.
    Albuquerque, F. N.
    Sales, A. L. F.
    Salvino, N. F. A.
    Sousa, L. T.
    Albuquerque, D. C.
    Batista, E.
    Matias, C.
    Nogueira, M. A.
    Proenca, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 112 - 112
  • [34] "Real World" Eligibility for Sacubitril/ Valsartan in Unselected Heart Failure Patients: Data From the Swedish Heart Failure Registry
    Simpson, Joanne
    Benson, Lina
    Jhund, Pardeep S.
    Dahlstrom, Ulf
    McMurray, John J.
    Lund, Lars H.
    CIRCULATION, 2016, 134
  • [35] SACUBITRIL/VALSARTAN IN HEART FAILURE: PROJECTED HEALTH OUTCOMES IN PORTUGAL
    Afonso-Silva, M.
    Laires, P. A.
    VALUE IN HEALTH, 2018, 21 : S93 - S93
  • [36] SACUBITRIL/VALSARTAN IN "REAL WORLD" HEART FAILURE PATIENTS: FOCUS ON RENAL FUNCTION AND DRUG TITRATION
    Bonini, Niccolo
    Albini, Alessandro
    Venturelli, Andrea
    Maisano, Anna
    Luli, Jozef
    Vitolo, Marco
    Imberti, Jacopo Francesco
    Valenti, Anna Chiara
    Righelli, Ilaria
    Cataldo, Paolo
    Muto, Federico
    Tosetti, Alberto
    Boriani, Giuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [37] Renal protection in chronic heart failure: focus on sacubitril/valsartan
    Pontremoli, Roberto
    Borghi, Claudio
    Filardi, Pasquale Perrone
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 445 - 452
  • [38] REAL-WORLD IMPACT OF SACUBITRIL/VALSARTAN ON THE QUALITY OF LIFE OF HEART FAILURE PATIENTS IN PORTUGAL
    Afonso Nogueira, M.
    Afonso-Silva, M.
    Gomes, M.
    Andreozzi, V
    Vandewalle, B.
    Costa Ferreira, F.
    Monica, L.
    Cruz, L.
    Guimaraes, M.
    Proenca, G.
    VALUE IN HEALTH, 2020, 23 : S504 - S505
  • [39] The safety of sacubitril-valsartan for the treatment of chronic heart failure
    Tyler, Jeffrey M.
    Teerlink, John R.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (02) : 257 - 263
  • [40] SACUBITRIL/VALSARTAN IN CHRONIC SYMPTOMATIC HEART FAILURE WITH REDUCED EJECTION FRACTION: FIRST CLINICAL EXPERIENCE FROM A LARGE UK TERTIARY CENTRE
    Ali, Danish
    Riley, Fiona
    Kirkland, Stephanie
    Hyland, Jacqui
    Banerjee, Prithwish
    HEART, 2017, 103 : A1 - A1
12345